Insmed (INSM) Misses Q1 EPS by 7c, Beats on Revenue

Insmed (NASDAQ: INSM) reported Q1 EPS of ($1.42), $0.07 worse than the analyst estimate of ($1.35). Revenue for the quarter came in at $92.82 million versus the consensus estimate of $90.78 million.

For earnings history and earnings-related data on Insmed (INSM) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• XP Inc eyes US banking license as next business step
• Is Treasury selloff a major issue for stock market bulls?